Elanco Animal Health ELAN
NYSE ELAN
$22.10 +0.33 (+1.54%)
As of: Oct 2, 2026 · 2:49 PM EDT

Elanco Animal Health (ELAN) Non Operating Interest Expenses (2018 - 2024)

Updated

Elanco Animal Health's Non Operating Interest Expenses came in at $58 million for Q3 2024, down 19.4% from $72 million a year earlier and down 10.8% from the prior quarter.

Analysis

Elanco Animal Health (ELAN) Non Operating Interest Expenses (2018 - 2024) Analysis & Trends

Over the trailing twelve months to Sep 30, 2024, Elanco Animal Health reported Non Operating Interest Expenses of $256 million, down 5.9% year-over-year; for FY2023, it came in at $277 million, up 14.9% from FY2022.

  • Non Operating Interest Expenses has increased in each of the last five years, with a five-year compound annual growth rate of 56.4% (FY2018 to FY2023).
  • Going back by year, Non Operating Interest Expenses was $241 million in FY2022 (+2.1%), $236 million in FY2021 (+57.3%), $150 million in FY2020 (+89.9%) and $79 million in FY2019 (+166.9%).
  • The Q3 2024 figure represents the lowest quarterly Non Operating Interest Expenses since Q1 2022.
  • Year-over-year, Non Operating Interest Expenses increased in six of the last eight quarters, with growth averaging 5.7%.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q1 2021 (growth of 281.3%), and the weakest in Q1 2020 (a decline of 23.1%).
  • Business Quant data shows ELAN's Non Operating Interest Expenses at $65 million (Q2 2024), $66 million (Q1 2024) and $67 million (Q4 2023) in the three quarters before Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Elanco Animal Health 11.18 Bn 9.18 Bn 798.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 58.00 Mn
Jun 30, 2024 65.00 Mn
Mar 31, 2024 66.00 Mn
Dec 31, 2023 67.00 Mn
Sep 30, 2023 72.00 Mn
Jun 30, 2023 74.00 Mn
Mar 31, 2023 64.00 Mn
Dec 31, 2022 62.00 Mn
Sep 30, 2022 60.00 Mn
Jun 30, 2022 67.00 Mn
Mar 31, 2022 52.00 Mn
Dec 31, 2021 55.00 Mn
Sep 30, 2021 60.00 Mn
Jun 30, 2021 60.00 Mn
Mar 31, 2021 61.00 Mn
Dec 31, 2020 60.40 Mn
Sep 30, 2020 48.00 Mn
Jun 30, 2020 25.00 Mn
Mar 31, 2020 16.00 Mn
Dec 31, 2019 18.70 Mn
API Access

Elanco Animal Health Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ELAN&period=max&api_key=YOUR_API_KEY